An integrative systems genetic analysis of mammalian lipid metabolism

Dysregulation of lipid homeostasis is a precipitating event in the pathogenesis and progression of hepatosteatosis and metabolic syndrome. These conditions are highly prevalent in developed societies and currently have limited options for diagnostic and therapeutic intervention. Here, using a proteo...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 567; no. 7747; pp. 187 - 193
Main Authors Parker, Benjamin L., Calkin, Anna C., Seldin, Marcus M., Keating, Michael F., Tarling, Elizabeth J., Yang, Pengyi, Moody, Sarah C., Liu, Yingying, Zerenturk, Eser J., Needham, Elise J., Miller, Matthew L., Clifford, Bethan L., Morand, Pauline, Watt, Matthew J., Meex, Ruth C. R., Peng, Kang-Yu, Lee, Richard, Jayawardana, Kaushala, Pan, Calvin, Mellett, Natalie A., Weir, Jacquelyn M., Lazarus, Ross, Lusis, Aldons J., Meikle, Peter J., James, David E., de Aguiar Vallim, Thomas Q., Drew, Brian G.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2019
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dysregulation of lipid homeostasis is a precipitating event in the pathogenesis and progression of hepatosteatosis and metabolic syndrome. These conditions are highly prevalent in developed societies and currently have limited options for diagnostic and therapeutic intervention. Here, using a proteomic and lipidomic-wide systems genetic approach, we interrogated lipid regulatory networks in 107 genetically distinct mouse strains to reveal key insights into the control and network structure of mammalian lipid metabolism. These include the identification of plasma lipid signatures that predict pathological lipid abundance in the liver of mice and humans, defining subcellular localization and functionality of lipid-related proteins, and revealing functional protein and genetic variants that are predicted to modulate lipid abundance. Trans-omic analyses using these datasets facilitated the identification and validation of PSMD9 as a previously unknown lipid regulatory protein. Collectively, our study serves as a rich resource for probing mammalian lipid metabolism and provides opportunities for the discovery of therapeutic agents and biomarkers in the setting of hepatic lipotoxicity. The integration of liver and plasma quantitative lipidomic and proteomic data from 107 distinct mouse strains provides important insights into regulators of mammalian lipid metabolism.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author contributions B.G.D., T.Q.d.A.V., A.C.C. and E.J.T. conceived the original concept. B.G.D., T.Q.d.A.V, A.C.C., B.L.P., M.M.S. and D.E.J. conceptualized the study and designed, performed, oversaw, interpreted and generated data and figures. B.L.P. and D.E.J. generated, analysed and interpreted the proteomic datasets. P.J.M. supervised the generation, analysis and interpretation of lipidomics data. A.J.L. advised on study design and systems genetics analysis, and provided access to data, software and reagents. B.G.D., B.L.P., T.Q.d.A.V., M.M.S., A.C.C., M.F.K., S.C.M., Y.L., E.J.Z., N.A.M., E.J.N., M.L.M., B.L.C., P.M., M.J.W., R.C.R.M., K.-Y.P., R. Lazarus and J.M.W. provided reagents, generated data and contributed to figure production. Specifically, B.L.C., P.M. and M.L.M. performed and analysed in vivo ASO experiments and data, and M.J.W., R.C.R.M. and K.-Y.P. performed and provided data for human plasma lipid signature validations. R. Lee provided access to, and expertise pertaining to ASO generation and delivery. M.M.S., B.L.P., B.G.D., K.J., C.P., R. Lazarus and P.Y. performed bioinformatics analyses. B.G.D., B.L.P., T.Q.d.A.V., A.C.C., M.M.S. and D.E.J. wrote the manuscript. All authors read and edited the manuscript.
ISSN:0028-0836
1476-4687
1476-4687
DOI:10.1038/s41586-019-0984-y